News | Breast Density | January 13, 2021

DenseBreast-info Launches Updated Website

DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content

DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content

January 13, 2021 — DenseBreast-info.org (DB-I) invites health providers seeking the most up-to-date medically-sourced educational materials about the screening and risk implications of dense breast tissue and value of supplemental screening to visit the newly re-launched DB-I website at www.DenseBreast-info.org. Originally launched in 2015, the DB-I website has continued to evolve to meet the needs of providers and patients in the United States and around the world on the topic of breast density with expanded content and educational tools. In addition to featuring a new look, the DB-I website has been revamped to support a more user-friendly experience and address the increasing reach of the DB-I website, growing global interactions and to provide easier access to the substantial volume of information. New educational tools and resources include:

Patient Resource Section – features downloadable education resources in 14 languages

Expanded Spanish-Language Hub – updated screening guidance and FAQs

State Density Inform Laws – new downloads and searchable Patient Inform and Insurance legislation

DB-I published research/webinars

“As the conversation around breast density and personalized screening grows, the need for high quality medically sourced educational materials and tools has also increased. With more than 200,000 visits to the DB-I website in 2020 and nearly 300,000 projected for 2021, it is critical to continually add resources, as well as streamline the website to give providers quick and easy access to important content,” said JoAnn Pushkin, Executive Director, DenseBreast-info.

For more information: densebreast-info.org/

Related Content

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
ACR releases 13 new topics and five revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions
News | Radiology Imaging | April 26, 2021
April 26, 2021 — The American College of Radiology (ACR) released an update to its...
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S.
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...
Women at high risk of breast cancer face cost-associated barriers to care even when they have health insurance, a new study has found.

Getty Images

News | Women's Health | April 22, 2021
April 22, 2021 — Women at high risk of breast cancer face cost-associated barriers to care even when they have health